Global Eczema Therapeutics Market 2024-2028
Description
Global Eczema Therapeutics Market 2024-2028
The eczema therapeutics market is forecasted to grow by USD 5.81 bn during 2023-2028, accelerating at a CAGR of 10.28% during the forecast period. The report on the eczema therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of atopic dermatitis, increasing product launches for treating eczema, and increase in demand for over-the-counter (OTC) eczema drugs among end-users.
Technavio's eczema therapeutics market is segmented as below:
By Application
- Atopic dermatitis
- Contact dermatitis
- Other indication
- Hospital and clinics
- Online pharmacies
- Retail pharmacies
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the eczema therapeutics market covers the following areas:
- Eczema therapeutics market sizing
- Eczema therapeutics market forecast
- Eczema therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
172 Pages
- 1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary - Chart on Market Overview
- Exhibit 02: Executive Summary - Data Table on Market Overview
- Exhibit 03: Executive Summary - Chart on Global Market Characteristics
- Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
- Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
- Exhibit 07: Executive Summary - Chart on Incremental Growth
- Exhibit 08: Executive Summary - Data Table on Incremental Growth
- Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
- 2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
- 3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
- 4 Historic Market Size
- 4.1 Global eczema therapeutics market 2018 - 2022
- Exhibit 18: Historic Market Size - Data Table on global eczema therapeutics market 2018 - 2022 ($ billion)
- 4.2 Application Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
- 4.3 Distribution channel Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size - Distribution channel Segment 2018 - 2022 ($ billion)
- 4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
- 4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
- 5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
- 6 Market Segmentation by Application
- 6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
- 6.2 Comparison by Application
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application
- 6.3 Atopic dermatitis - Market size and forecast 2023-2028
- Exhibit 34: Chart on Atopic dermatitis - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Atopic dermatitis - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Atopic dermatitis - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Atopic dermatitis - Year-over-year growth 2023-2028 (%)
- 6.4 Contact dermatitis - Market size and forecast 2023-2028
- Exhibit 38: Chart on Contact dermatitis - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Contact dermatitis - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Contact dermatitis - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Contact dermatitis - Year-over-year growth 2023-2028 (%)
- 6.5 Other indication - Market size and forecast 2023-2028
- Exhibit 42: Chart on Other indication - Market size and forecast 2023-2028 ($ billion)
- Exhibit 43: Data Table on Other indication - Market size and forecast 2023-2028 ($ billion)
- Exhibit 44: Chart on Other indication - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Other indication - Year-over-year growth 2023-2028 (%)
- 6.6 Market opportunity by Application
- Exhibit 46: Market opportunity by Application ($ billion)
- Exhibit 47: Data Table on Market opportunity by Application ($ billion)
- 7 Market Segmentation by Distribution Channel
- 7.1 Market segments
- Exhibit 48: Chart on Distribution Channel - Market share 2023-2028 (%)
- Exhibit 49: Data Table on Distribution Channel - Market share 2023-2028 (%)
- 7.2 Comparison by Distribution Channel
- Exhibit 50: Chart on Comparison by Distribution Channel
- Exhibit 51: Data Table on Comparison by Distribution Channel
- 7.3 Hospital and clinics - Market size and forecast 2023-2028
- Exhibit 52: Chart on Hospital and clinics - Market size and forecast 2023-2028 ($ billion)
- Exhibit 53: Data Table on Hospital and clinics - Market size and forecast 2023-2028 ($ billion)
- Exhibit 54: Chart on Hospital and clinics - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Hospital and clinics - Year-over-year growth 2023-2028 (%)
- 7.4 Online pharmacies - Market size and forecast 2023-2028
- Exhibit 56: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 57: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 58: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
- 7.5 Retail pharmacies - Market size and forecast 2023-2028
- Exhibit 60: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 61: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 62: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
- 7.6 Market opportunity by Distribution Channel
- Exhibit 64: Market opportunity by Distribution Channel ($ billion)
- Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ billion)
- 8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
- Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 9.2 Geographic comparison
- Exhibit 69: Chart on Geographic comparison
- Exhibit 70: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 Germany - Market size and forecast 2023-2028
- Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.9 UK - Market size and forecast 2023-2028
- Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.10 China - Market size and forecast 2023-2028
- Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.11 Canada - Market size and forecast 2023-2028
- Exhibit 103: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
- Exhibit 104: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
- Exhibit 105: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity By Geographical Landscape
- Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
- Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
- 10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 109: Impact of drivers and challenges in 2023 and 2028
- 10.4 Market trends
- 11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 111: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 112: Impact of key risks on business
- 12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 113: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 114: Matrix on vendor position and classification
- 12.3 AbbVie Inc.
- Exhibit 115: AbbVie Inc. - Overview
- Exhibit 116: AbbVie Inc. - Product / Service
- Exhibit 117: AbbVie Inc. - Key news
- Exhibit 118: AbbVie Inc. - Key offerings
- 12.4 Alliance Pharma PLC
- Exhibit 119: Alliance Pharma PLC - Overview
- Exhibit 120: Alliance Pharma PLC - Business segments
- Exhibit 121: Alliance Pharma PLC - Key offerings
- Exhibit 122: Alliance Pharma PLC - Segment focus
- 12.5 Amneal Pharmaceuticals Inc.
- Exhibit 123: Amneal Pharmaceuticals Inc. - Overview
- Exhibit 124: Amneal Pharmaceuticals Inc. - Business segments
- Exhibit 125: Amneal Pharmaceuticals Inc. - Key news
- Exhibit 126: Amneal Pharmaceuticals Inc. - Key offerings
- Exhibit 127: Amneal Pharmaceuticals Inc. - Segment focus
- 12.6 AstraZeneca PLC
- Exhibit 128: AstraZeneca PLC - Overview
- Exhibit 129: AstraZeneca PLC - Product / Service
- Exhibit 130: AstraZeneca PLC - Key news
- Exhibit 131: AstraZeneca PLC - Key offerings
- 12.7 Bausch Health Companies Inc.
- Exhibit 132: Bausch Health Companies Inc. - Overview
- Exhibit 133: Bausch Health Companies Inc. - Business segments
- Exhibit 134: Bausch Health Companies Inc. - Key news
- Exhibit 135: Bausch Health Companies Inc. - Key offerings
- Exhibit 136: Bausch Health Companies Inc. - Segment focus
- 12.8 Bayer AG
- Exhibit 137: Bayer AG - Overview
- Exhibit 138: Bayer AG - Business segments
- Exhibit 139: Bayer AG - Key news
- Exhibit 140: Bayer AG - Key offerings
- Exhibit 141: Bayer AG - Segment focus
- 12.9 Cadila Pharmaceuticals Ltd.
- Exhibit 142: Cadila Pharmaceuticals Ltd. - Overview
- Exhibit 143: Cadila Pharmaceuticals Ltd. - Product / Service
- Exhibit 144: Cadila Pharmaceuticals Ltd. - Key news
- Exhibit 145: Cadila Pharmaceuticals Ltd. - Key offerings
- 12.10 Eli Lilly and Co.
- Exhibit 146: Eli Lilly and Co. - Overview
- Exhibit 147: Eli Lilly and Co. - Product / Service
- Exhibit 148: Eli Lilly and Co. - Key news
- Exhibit 149: Eli Lilly and Co. - Key offerings
- 12.11 LEO Pharma AS
- Exhibit 150: LEO Pharma AS - Overview
- Exhibit 151: LEO Pharma AS - Business segments
- Exhibit 152: LEO Pharma AS - Key offerings
- Exhibit 153: LEO Pharma AS - Segment focus
- 12.12 Lupin Ltd.
- Exhibit 154: Lupin Ltd. - Overview
- Exhibit 155: Lupin Ltd. - Product / Service
- Exhibit 156: Lupin Ltd. - Key news
- Exhibit 157: Lupin Ltd. - Key offerings
- 12.13 Merck and Co. Inc.
- Exhibit 158: Merck and Co. Inc. - Overview
- Exhibit 159: Merck and Co. Inc. - Business segments
- Exhibit 160: Merck and Co. Inc. - Key news
- Exhibit 161: Merck and Co. Inc. - Key offerings
- Exhibit 162: Merck and Co. Inc. - Segment focus
- 12.14 Novartis AG
- Exhibit 163: Novartis AG - Overview
- Exhibit 164: Novartis AG - Business segments
- Exhibit 165: Novartis AG - Key news
- Exhibit 166: Novartis AG - Key offerings
- Exhibit 167: Novartis AG - Segment focus
- 12.15 Pfizer Inc.
- Exhibit 168: Pfizer Inc. - Overview
- Exhibit 169: Pfizer Inc. - Product / Service
- Exhibit 170: Pfizer Inc. - Key news
- Exhibit 171: Pfizer Inc. - Key offerings
- 12.16 Sanofi SA
- Exhibit 172: Sanofi SA - Overview
- Exhibit 173: Sanofi SA - Business segments
- Exhibit 174: Sanofi SA - Key news
- Exhibit 175: Sanofi SA - Key offerings
- Exhibit 176: Sanofi SA - Segment focus
- 12.17 Viatris Inc.
- Exhibit 177: Viatris Inc. - Overview
- Exhibit 178: Viatris Inc. - Business segments
- Exhibit 179: Viatris Inc. - Key news
- Exhibit 180: Viatris Inc. - Key offerings
- Exhibit 181: Viatris Inc. - Segment focus
- 13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 182: Inclusions checklist
- Exhibit 183: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 184: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 185: Research methodology
- Exhibit 186: Validation techniques employed for market sizing
- Exhibit 187: Information sources
- 13.5 List of abbreviations
- Exhibit 188: List of abbreviations
- Exhibits:
- Exhibits1: Executive Summary - Chart on Market Overview
- Exhibits2: Executive Summary - Data Table on Market Overview
- Exhibits3: Executive Summary - Chart on Global Market Characteristics
- Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
- Exhibits5: Executive Summary - Chart on Market Segmentation by Application
- Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
- Exhibits7: Executive Summary - Chart on Incremental Growth
- Exhibits8: Executive Summary - Data Table on Incremental Growth
- Exhibits9: Executive Summary - Chart on Vendor Market Positioning
- Exhibits10: Parent market
- Exhibits11: Market Characteristics
- Exhibits12: Offerings of vendors included in the market definition
- Exhibits13: Market segments
- Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits18: Historic Market Size - Data Table on global eczema therapeutics market 2018 - 2022 ($ billion)
- Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
- Exhibits20: Historic Market Size - Distribution channel Segment 2018 - 2022 ($ billion)
- Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
- Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
- Exhibits23: Five forces analysis - Comparison between 2023 and 2028
- Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
- Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
- Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
- Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
- Exhibits29: Chart on Market condition - Five forces 2023 and 2028
- Exhibits30: Chart on Application - Market share 2023-2028 (%)
- Exhibits31: Data Table on Application - Market share 2023-2028 (%)
- Exhibits32: Chart on Comparison by Application
- Exhibits33: Data Table on Comparison by Application
- Exhibits34: Chart on Atopic dermatitis - Market size and forecast 2023-2028 ($ billion)
- Exhibits35: Data Table on Atopic dermatitis - Market size and forecast 2023-2028 ($ billion)
- Exhibits36: Chart on Atopic dermatitis - Year-over-year growth 2023-2028 (%)
- Exhibits37: Data Table on Atopic dermatitis - Year-over-year growth 2023-2028 (%)
- Exhibits38: Chart on Contact dermatitis - Market size and forecast 2023-2028 ($ billion)
- Exhibits39: Data Table on Contact dermatitis - Market size and forecast 2023-2028 ($ billion)
- Exhibits40: Chart on Contact dermatitis - Year-over-year growth 2023-2028 (%)
- Exhibits41: Data Table on Contact dermatitis - Year-over-year growth 2023-2028 (%)
- Exhibits42: Chart on Other indication - Market size and forecast 2023-2028 ($ billion)
- Exhibits43: Data Table on Other indication - Market size and forecast 2023-2028 ($ billion)
- Exhibits44: Chart on Other indication - Year-over-year growth 2023-2028 (%)
- Exhibits45: Data Table on Other indication - Year-over-year growth 2023-2028 (%)
- Exhibits46: Market opportunity by Application ($ billion)
- Exhibits47: Data Table on Market opportunity by Application ($ billion)
- Exhibits48: Chart on Distribution Channel - Market share 2023-2028 (%)
- Exhibits49: Data Table on Distribution Channel - Market share 2023-2028 (%)
- Exhibits50: Chart on Comparison by Distribution Channel
- Exhibits51: Data Table on Comparison by Distribution Channel
- Exhibits52: Chart on Hospital and clinics - Market size and forecast 2023-2028 ($ billion)
- Exhibits53: Data Table on Hospital and clinics - Market size and forecast 2023-2028 ($ billion)
- Exhibits54: Chart on Hospital and clinics - Year-over-year growth 2023-2028 (%)
- Exhibits55: Data Table on Hospital and clinics - Year-over-year growth 2023-2028 (%)
- Exhibits56: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibits57: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibits58: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibits59: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibits60: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibits61: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
- Exhibits62: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibits63: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibits64: Market opportunity by Distribution Channel ($ billion)
- Exhibits65: Data Table on Market opportunity by Distribution Channel ($ billion)
- Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
- Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
- Exhibits69: Chart on Geographic comparison
- Exhibits70: Data Table on Geographic comparison
- Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
- Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
- Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
- Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ billion)
- Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
- Exhibits103: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
- Exhibits104: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
- Exhibits105: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibits106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
- Exhibits107: Market opportunity By Geographical Landscape ($ billion)
- Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
- Exhibits109: Impact of drivers and challenges in 2023 and 2028
- Exhibits110: Overview on Criticality of inputs and Factors of differentiation
- Exhibits111: Overview on factors of disruption
- Exhibits112: Impact of key risks on business
- Exhibits113: Vendors covered
- Exhibits114: Matrix on vendor position and classification
- Exhibits115: AbbVie Inc. - Overview
- Exhibits116: AbbVie Inc. - Product / Service
- Exhibits117: AbbVie Inc. - Key news
- Exhibits118: AbbVie Inc. - Key offerings
- Exhibits119: Alliance Pharma PLC - Overview
- Exhibits120: Alliance Pharma PLC - Business segments
- Exhibits121: Alliance Pharma PLC - Key offerings
- Exhibits122: Alliance Pharma PLC - Segment focus
- Exhibits123: Amneal Pharmaceuticals Inc. - Overview
- Exhibits124: Amneal Pharmaceuticals Inc. - Business segments
- Exhibits125: Amneal Pharmaceuticals Inc. - Key news
- Exhibits126: Amneal Pharmaceuticals Inc. - Key offerings
- Exhibits127: Amneal Pharmaceuticals Inc. - Segment focus
- Exhibits128: AstraZeneca PLC - Overview
- Exhibits129: AstraZeneca PLC - Product / Service
- Exhibits130: AstraZeneca PLC - Key news
- Exhibits131: AstraZeneca PLC - Key offerings
- Exhibits132: Bausch Health Companies Inc. - Overview
- Exhibits133: Bausch Health Companies Inc. - Business segments
- Exhibits134: Bausch Health Companies Inc. - Key news
- Exhibits135: Bausch Health Companies Inc. - Key offerings
- Exhibits136: Bausch Health Companies Inc. - Segment focus
- Exhibits137: Bayer AG - Overview
- Exhibits138: Bayer AG - Business segments
- Exhibits139: Bayer AG - Key news
- Exhibits140: Bayer AG - Key offerings
- Exhibits141: Bayer AG - Segment focus
- Exhibits142: Cadila Pharmaceuticals Ltd. - Overview
- Exhibits143: Cadila Pharmaceuticals Ltd. - Product / Service
- Exhibits144: Cadila Pharmaceuticals Ltd. - Key news
- Exhibits145: Cadila Pharmaceuticals Ltd. - Key offerings
- Exhibits146: Eli Lilly and Co. - Overview
- Exhibits147: Eli Lilly and Co. - Product / Service
- Exhibits148: Eli Lilly and Co. - Key news
- Exhibits149: Eli Lilly and Co. - Key offerings
- Exhibits150: LEO Pharma AS - Overview
- Exhibits151: LEO Pharma AS - Business segments
- Exhibits152: LEO Pharma AS - Key offerings
- Exhibits153: LEO Pharma AS - Segment focus
- Exhibits154: Lupin Ltd. - Overview
- Exhibits155: Lupin Ltd. - Product / Service
- Exhibits156: Lupin Ltd. - Key news
- Exhibits157: Lupin Ltd. - Key offerings
- Exhibits158: Merck and Co. Inc. - Overview
- Exhibits159: Merck and Co. Inc. - Business segments
- Exhibits160: Merck and Co. Inc. - Key news
- Exhibits161: Merck and Co. Inc. - Key offerings
- Exhibits162: Merck and Co. Inc. - Segment focus
- Exhibits163: Novartis AG - Overview
- Exhibits164: Novartis AG - Business segments
- Exhibits165: Novartis AG - Key news
- Exhibits166: Novartis AG - Key offerings
- Exhibits167: Novartis AG - Segment focus
- Exhibits168: Pfizer Inc. - Overview
- Exhibits169: Pfizer Inc. - Product / Service
- Exhibits170: Pfizer Inc. - Key news
- Exhibits171: Pfizer Inc. - Key offerings
- Exhibits172: Sanofi SA - Overview
- Exhibits173: Sanofi SA - Business segments
- Exhibits174: Sanofi SA - Key news
- Exhibits175: Sanofi SA - Key offerings
- Exhibits176: Sanofi SA - Segment focus
- Exhibits177: Viatris Inc. - Overview
- Exhibits178: Viatris Inc. - Business segments
- Exhibits179: Viatris Inc. - Key news
- Exhibits180: Viatris Inc. - Key offerings
- Exhibits181: Viatris Inc. - Segment focus
- Exhibits182: Inclusions checklist
- Exhibits183: Exclusions checklist
- Exhibits184: Currency conversion rates for US$
- Exhibits185: Research methodology
- Exhibits186: Validation techniques employed for market sizing
- Exhibits187: Information sources
- Exhibits188: List of abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
